150 related articles for article (PubMed ID: 30897286)
1. Brain region-specific regulation of histone acetylation and efflux transporters in mice.
You D; Shin HM; Mosaad F; Richardson JR; Aleksunes LM
J Biochem Mol Toxicol; 2019 Jun; 33(6):e22318. PubMed ID: 30897286
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic Regulation of Multidrug Resistance Protein 1 and Breast Cancer Resistance Protein Transporters by Histone Deacetylase Inhibition.
You D; Richardson JR; Aleksunes LM
Drug Metab Dispos; 2020 Jun; 48(6):459-480. PubMed ID: 32193359
[TBL] [Abstract][Full Text] [Related]
3. Increased MDR1 Transporter Expression in Human Brain Endothelial Cells Through Enhanced Histone Acetylation and Activation of Aryl Hydrocarbon Receptor Signaling.
You D; Wen X; Gorczyca L; Morris A; Richardson JR; Aleksunes LM
Mol Neurobiol; 2019 Oct; 56(10):6986-7002. PubMed ID: 30963442
[TBL] [Abstract][Full Text] [Related]
4. Histone modifications at the ABCG2 promoter following treatment with histone deacetylase inhibitor mirror those in multidrug-resistant cells.
To KK; Polgar O; Huff LM; Morisaki K; Bates SE
Mol Cancer Res; 2008 Jan; 6(1):151-64. PubMed ID: 18234970
[TBL] [Abstract][Full Text] [Related]
5. Elevated level of lysine 9-acetylated histone H3 at the MDR1 promoter in multidrug-resistant cells.
Toth M; Boros IM; Balint E
Cancer Sci; 2012 Apr; 103(4):659-69. PubMed ID: 22320423
[TBL] [Abstract][Full Text] [Related]
6. Valproic Acid-Induced Upregulation of Multidrug Efflux Transporter ABCG2/BCRP via PPAR
Kukal S; Bora S; Kanojia N; Singh P; Paul PR; Rawat C; Sagar S; Bhatraju NK; Grewal GK; Singh A; Kukreti S; Satyamoorthy K; Kukreti R
Mol Pharmacol; 2023 Mar; 103(3):145-157. PubMed ID: 36414374
[TBL] [Abstract][Full Text] [Related]
7. Resistance after chronic application of the HDAC-inhibitor valproic acid is associated with elevated Akt activation in renal cell carcinoma in vivo.
Juengel E; Makarević J; Tsaur I; Bartsch G; Nelson K; Haferkamp A; Blaheta RA
PLoS One; 2013; 8(1):e53100. PubMed ID: 23372654
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory regulation of ATP binding cassette efflux transporter expression and function in microglia.
Gibson CJ; Hossain MM; Richardson JR; Aleksunes LM
J Pharmacol Exp Ther; 2012 Dec; 343(3):650-60. PubMed ID: 22942241
[TBL] [Abstract][Full Text] [Related]
9. Valproate increases dopamine transporter expression through histone acetylation and enhanced promoter binding of Nurr1.
Green AL; Zhan L; Eid A; Zarbl H; Guo GL; Richardson JR
Neuropharmacology; 2017 Oct; 125():189-196. PubMed ID: 28743636
[TBL] [Abstract][Full Text] [Related]
10. Histone deacetylase inhibitors, valproic acid and trichostatin-A induce apoptosis and affect acetylation status of p53 in ERG-positive prostate cancer cells.
Fortson WS; Kayarthodi S; Fujimura Y; Xu H; Matthews R; Grizzle WE; Rao VN; Bhat GK; Reddy ES
Int J Oncol; 2011 Jul; 39(1):111-9. PubMed ID: 21519790
[TBL] [Abstract][Full Text] [Related]
11. Effect of the ATP-binding cassette drug transporters ABCB1, ABCG2, and ABCC2 on erlotinib hydrochloride (Tarceva) disposition in in vitro and in vivo pharmacokinetic studies employing Bcrp1-/-/Mdr1a/1b-/- (triple-knockout) and wild-type mice.
Marchetti S; de Vries NA; Buckle T; Bolijn MJ; van Eijndhoven MA; Beijnen JH; Mazzanti R; van Tellingen O; Schellens JH
Mol Cancer Ther; 2008 Aug; 7(8):2280-7. PubMed ID: 18723475
[TBL] [Abstract][Full Text] [Related]
12. Induction of DARPP-32 by brain-derived neurotrophic factor in striatal neurons in vitro is modified by histone deacetylase inhibitors and Nab2.
Chandwani S; Keilani S; Ortiz-Virumbrales M; Morant A; Bezdecny S; Ehrlich ME
PLoS One; 2013; 8(10):e76842. PubMed ID: 24204683
[TBL] [Abstract][Full Text] [Related]
13. HDAC inhibition through valproic acid modulates the methylation profiles in human embryonic kidney cells.
Ganai SA; Kalladi SM; Mahadevan V
J Biomol Struct Dyn; 2015; 33(6):1185-97. PubMed ID: 25012937
[TBL] [Abstract][Full Text] [Related]
14. Validation of Human MDR1-MDCK and BCRP-MDCK Cell Lines to Improve the Prediction of Brain Penetration.
Feng B; West M; Patel NC; Wager T; Hou X; Johnson J; Tremaine L; Liras J
J Pharm Sci; 2019 Jul; 108(7):2476-2483. PubMed ID: 30794795
[TBL] [Abstract][Full Text] [Related]
15. Role of histone acetylation in the stimulatory effect of valproic acid on vascular endothelial tissue-type plasminogen activator expression.
Larsson P; Ulfhammer E; Magnusson M; Bergh N; Lunke S; El-Osta A; Medcalf RL; Svensson PA; Karlsson L; Jern S
PLoS One; 2012; 7(2):e31573. PubMed ID: 22363677
[TBL] [Abstract][Full Text] [Related]
16. P-glycoprotein (MDR1/ABCB1) and breast cancer resistance protein (BCRP/ABCG2) restrict brain accumulation of the JAK1/2 inhibitor, CYT387.
Durmus S; Xu N; Sparidans RW; Wagenaar E; Beijnen JH; Schinkel AH
Pharmacol Res; 2013 Oct; 76():9-16. PubMed ID: 23827160
[TBL] [Abstract][Full Text] [Related]
17. Cross-communication between histone H3 and H4 acetylation and Akt-mTOR signalling in prostate cancer cells.
Makarević J; Tawanaie N; Juengel E; Reiter M; Mani J; Tsaur I; Bartsch G; Haferkamp A; Blaheta RA
J Cell Mol Med; 2014 Jul; 18(7):1460-6. PubMed ID: 24779401
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic evidence of an Ac/Dc axis by VPA and SAHA.
Lunke S; Maxwell S; Khurana I; K N H; Okabe J; Al-Hasani K; El-Osta A
Clin Epigenetics; 2021 Mar; 13(1):58. PubMed ID: 33743782
[TBL] [Abstract][Full Text] [Related]
19. Trichostatin A induces 5-lipoxygenase promoter activity and mRNA expression via inhibition of histone deacetylase 2 and 3.
Pufahl L; Katryniok C; Schnur N; Sorg BL; Metzner J; Grez M; Steinhilber D
J Cell Mol Med; 2012 Jul; 16(7):1461-73. PubMed ID: 21883892
[TBL] [Abstract][Full Text] [Related]
20. Liver X receptor regulates expression of MRP2 but not that of MDR1 and BCRP in the liver.
Chisaki I; Kobayashi M; Itagaki S; Hirano T; Iseki K
Biochim Biophys Acta; 2009 Nov; 1788(11):2396-403. PubMed ID: 19728987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
